Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection
Recommended Citation
Dakay K, Kaur G, Gulko E, Santarelli J, Bowers C, Mayer SA, Gandhi CD, Al-Mufti F. Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. J Stroke Cerebrovasc Dis 2020; 29(9):105011-105011.
Document Type
Article
Publication Date
6-5-2020
Publication Title
J Stroke Cerebrovasc Dis
Abstract
The current COVID-19 pandemic has recently brought to attention the myriad of neurologic sequelae associated with Coronavirus infection including the predilection for stroke, particularly in young patients. Reversible cerebral vasoconstriction syndrome (RCVS) is a well-described clinical syndrome leading to vasoconstriction in the intracranial vessels, and has been associated with convexity subarachnoid hemorrhage and occasionally cervical artery dissection. It is usually reported in the context of a trigger such as medications, recreational drugs, or the postpartum state; however, it has not been described in COVID-19 infection. We report a case of both cervical vertebral artery dissection as well as convexity subarachnoid hemorrhage due to RCVS, in a patient with COVID-19 infection and no other triggers.
Medical Subject Headings
Adult; Betacoronavirus; Cerebral Arteries; Coronavirus Infections; Female; Headache Disorders, Primary; Host-Pathogen Interactions; Humans; Pandemics; Pneumonia, Viral; Risk Factors; Subarachnoid Hemorrhage; Syndrome; Vasoconstriction; Vasodilation; Vertebral Artery Dissection
PubMed ID
32807426
ePublication
ePub ahead of print
Volume
29
Issue
9
First Page
105011
Last Page
105011
